abstract |
The present invention relates to an antigen gene of a novel hepatitis A virus and a plant transformed with the gene, and more specifically, to an antigen gene of a novel hepatitis A virus synthesized by gene codon optimization, and a recombinant containing the gene. It relates to a vector and a plant transformed with the recombinant vector.n n n According to the present invention, the recombinant hepatitis A vaccine material can be produced with high efficiency by using the antigen gene of the synthetic hepatitis A virus, and the transgenic plant expressing the hepatitis A virus antigen is a functional food material and oral dosage form. Useful as a vaccine material. |